Research ArticleArticle
Metabolism and Disposition in Humans of Raltegravir (MK-0518), an Anti-AIDS Drug Targeting the Human Immunodeficiency Virus 1 Integrase Enzyme
Kelem Kassahun, Ian McIntosh, Donghui Cui, David Hreniuk, Shelia Merschman, Kenneth Lasseter, Neal Azrolan, Marian Iwamoto, John A. Wagner and Larissa A. Wenning
Drug Metabolism and Disposition September 2007, 35 (9) 1657-1663; DOI: https://doi.org/10.1124/dmd.107.016196
Kelem Kassahun
Ian McIntosh
Donghui Cui
David Hreniuk
Shelia Merschman
Kenneth Lasseter
Neal Azrolan
Marian Iwamoto
John A. Wagner
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
Metabolism and Disposition in Humans of Raltegravir (MK-0518), an Anti-AIDS Drug Targeting the Human Immunodeficiency Virus 1 Integrase Enzyme
Kelem Kassahun, Ian McIntosh, Donghui Cui, David Hreniuk, Shelia Merschman, Kenneth Lasseter, Neal Azrolan, Marian Iwamoto, John A. Wagner and Larissa A. Wenning
Drug Metabolism and Disposition September 1, 2007, 35 (9) 1657-1663; DOI: https://doi.org/10.1124/dmd.107.016196
Research ArticleArticle
Metabolism and Disposition in Humans of Raltegravir (MK-0518), an Anti-AIDS Drug Targeting the Human Immunodeficiency Virus 1 Integrase Enzyme
Kelem Kassahun, Ian McIntosh, Donghui Cui, David Hreniuk, Shelia Merschman, Kenneth Lasseter, Neal Azrolan, Marian Iwamoto, John A. Wagner and Larissa A. Wenning
Drug Metabolism and Disposition September 1, 2007, 35 (9) 1657-1663; DOI: https://doi.org/10.1124/dmd.107.016196
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement